1.57
price up icon1.29%   0.02
pre-market  시장 영업 전:  1.62   0.05   +3.18%
loading
전일 마감가:
$1.55
열려 있는:
$1.56
하루 거래량:
118.06K
Relative Volume:
0.31
시가총액:
$160.08M
수익:
-
순이익/손실:
$-13.73M
주가수익비율:
-12.08
EPS:
-0.13
순현금흐름:
$-3.92M
1주 성능:
-10.29%
1개월 성능:
+9.03%
6개월 성능:
+130.61%
1년 성능:
+82.77%
1일 변동 폭
Value
$1.54
$1.58
1주일 범위
Value
$1.5299
$1.81
52주 변동 폭
Value
$0.6295
$1.91

Tiziana Life Sciences Ltd Stock (TLSA) Company Profile

Name
명칭
Tiziana Life Sciences Ltd
Name
전화
-
Name
주소
-
Name
직원
9
Name
트위터
@tizianals
Name
다음 수익 날짜
2024-05-27
Name
최신 SEC 제출 서류
Name
TLSA's Discussions on Twitter

TLSA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TLSA
Tiziana Life Sciences Ltd
1.57 160.08M 0 -13.73M -3.92M -0.13
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-12-22 개시 B. Riley Securities Buy
2018-12-17 개시 Laidlaw Buy

Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스

pulisher
Jun 16, 2025

Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Penny Stocks To Consider In June 2025 - simplywall.st

Jun 16, 2025
pulisher
Jun 13, 2025

Tiziana: Scope Of Foralumab Goes Beyond That Of Multiple Sclerosis Targeting (NASDAQ:TLSA) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana Life Sciences Adds Fifth Site for Phase 2 Foralumab Trial in Multiple Sclerosis - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Small cap wrap: Tiziana Life Sciences, Challenger Energy, Arrow Exploration... - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana expands Phase 2 MS trial to fifth site, commences patient dosing - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Breakthrough Multiple Sclerosis Treatment Enters Next Phase as Weill Cornell Joins Major Clinical Trial - Stock Titan

Jun 13, 2025
pulisher
Jun 13, 2025

Market movers: RH, Tiziana, Archer Aviation... - Proactive Investors

Jun 13, 2025
pulisher
Jun 13, 2025

Shares of Tiziana Life Sciences (TLSA) Climb on CEO's Upcoming P - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana shares rise on presentation date for foralumab data - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana CEO to present clinical advances of intranasal foralumab at BIO 2025 - Proactive financial news

Jun 13, 2025
pulisher
Jun 13, 2025

Tiziana Life Sciences to Present at the Bio International Convention - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Revolutionary Intranasal Treatment for MS and Alzheimer's: Tiziana CEO Reveals Latest Clinical Findings at BIO 2025 - Stock Titan

Jun 13, 2025
pulisher
May 27, 2025

Tiziana Life Sciences Ltd (TLSA) Stock: A Comprehensive 52-Week Review - investchronicle.com

May 27, 2025
pulisher
May 27, 2025

Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Up 15.3% – Still a Buy? - Defense World

May 27, 2025
pulisher
May 23, 2025

TLSA Advances Alzheimer's Treatment with Innovative Nasal Spray - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Interview Highlighting Intranasa - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease | TLSA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Tiziana Life Sciences Announces Breakthrough Advancement in Moderate Alzheimer’s Treatment with Intranasal Foralumab - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Breakthrough: First Alzheimer's Patient Shows Improvement with Revolutionary Nasal Antibody Treatment - Stock Titan

May 23, 2025
pulisher
May 16, 2025

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease - BioSpace

May 16, 2025
pulisher
May 16, 2025

Small cap wrap: Lancaster Resources, Cerro de Pasco, Tiziana Life Sciences, Nano One Materials... - Proactive financial news

May 16, 2025
pulisher
May 15, 2025

Tiziana reports reduction in microglial activation in Alzheimer’s case treated with nasal foralumab - Proactive financial news

May 15, 2025
pulisher
May 15, 2025

TLSA: Tiziana Life Sciences Study Shows Promise for Alzheimer's Treatment | TLSA Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Journal Of Clinical Nuclear Medicine Publishes Results Of Tiziana’S Nasal Foralumab In Study Treating Moderate Alzheimer's Disease - MENAFN.com

May 15, 2025
pulisher
May 15, 2025

Journal of Clinical Nuclear Medicine Publishes Results of - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Revolutionary Nasal Treatment Reduces Brain Inflammation in Moderate Alzheimer's Patient, Harvard Study Shows - Stock Titan

May 15, 2025
pulisher
May 12, 2025

Tiziana Life Sciences chairman increases stake to over 37% - Proactive financial news

May 12, 2025
pulisher
May 12, 2025

Executive Chairman Increases Stake in Tiziana Life Sciences (TLS - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Tiziana Life Sciences Announces Purchase of Shares by Chairman - The Manila Times

May 12, 2025
pulisher
May 10, 2025

Tiziana reports promising Alzheimer’s treatment results By Investing.com - Investing.com Nigeria

May 10, 2025
pulisher
May 10, 2025

Tiziana reports promising Alzheimer’s treatment results - Investing.com

May 10, 2025
pulisher
May 09, 2025

Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab - BioSpace

May 09, 2025
pulisher
May 09, 2025

Tiziana Reports PET data sees reduced neuroinflammation in patient treated with Intranasal Therapy - Proactive Investors

May 09, 2025
pulisher
May 09, 2025

Market movers: Lyft, US Gold, Tiziana Life Sciences... - Proactive Investors

May 09, 2025
pulisher
May 09, 2025

Tiziana Life Sciences reports reduced brain inflammation in Alzheimer’s patient treated with nasal foralumab - Proactive Investors

May 09, 2025
pulisher
May 09, 2025

TLSA: Tiziana Life Sciences Reports Positive PET Scan Results in Alzheimer's Treatment | TLSA Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Tiziana stock gains on data for Alzheimer's drug (TLSA:NASDAQ) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Tiziana Life Sciences Announces Significant Reduction In Microglia Activation In PET Scan Of Moderate Alzheimer's Patient Treated With Intranasal Foralumab - MENAFN.com

May 09, 2025
pulisher
May 09, 2025

Tiziana Life Sciences Announces Significant Reduction in - GlobeNewswire

May 09, 2025
pulisher
May 08, 2025

Tiziana Life Sciences’ intranasal MS candidate shows promise in open-label study - PMLiVE

May 08, 2025
pulisher
May 06, 2025

Small cap wrap: Tiziana Life Sciences, Millennial Potash, Century LIthium... - Proactive financial news

May 06, 2025
pulisher
May 06, 2025

Tiziana shares surge 21% on promising multiple sclerosis data - Proactive financial news

May 06, 2025
pulisher
May 06, 2025

Tiziana rises on positive results in multiple sclerosis treatment study - Seeking Alpha

May 06, 2025
pulisher
May 06, 2025

Tiziana reports encouraging results for nasal MS drug in early study - Proactive Investors

May 06, 2025
pulisher
May 06, 2025

TLSA's Nasal Foralumab Shows Promise in MS Treatment Study | TLS - GuruFocus

May 06, 2025
pulisher
May 06, 2025

TLSA's Nasal Foralumab Shows Promise in MS Treatment Study | TLSA Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Clinical Trial Success: Revolutionary Nasal Spray Halts Multiple Sclerosis Progression in Landmark Study - Stock Titan

May 06, 2025

Tiziana Life Sciences Ltd (TLSA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):